Form 4: Daxor Corp CEO Michael Feldschuh Increases Stake with Recent Stock Purchase
SEC Form 4 Filing
Daxor Corp's CEO, Michael Richard Feldschuh, recently acquired 1,000 shares of Daxor Common Stock at a price of $8.13 per share.
Summary
- On March 26, 2024, Michael Richard Feldschuh, the CEO of Daxor Corp, purchased 1,000 shares of Daxor Common Stock.
- The purchase price was $8.13 per share.
- Following this transaction, Feldschuh directly owns 210,631 shares of Daxor Common Stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's stock purchase, which suggests confidence in the company's prospects. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. CEO's buying shares in their own company is generally seen as a positive sign.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Date of stock purchase transaction |
| 03/27/2025 | Signature date of the Form 4 filing |
Keywords
Daxor Corp, Michael Feldschuh, stock purchase, Form 4, insider trading, DXR, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.